荷兰因慢加急性肝衰竭入住重症监护室患者出院后一年无移植存活率
荷兰全国性观察性队列纳入2012至2020年因肝硬化或门静脉高压首次并发症入住ICU的3035例患者,其中1819例(59.9%)为ACLF-3。ICU入院时ACLF分级在调整年龄、恶性肿瘤状态和MELD评分后,与出院后1年无移植存活无独立关联。
要点
- ICU入院时ACLF-3患者占59.9%(1819/3035),出院后1年无移植存活率为0.53(95%CI 0.49-0.58)。
- 无ACLF患者出院后1年无移植存活率最高,为0.71(95%CI 0.66-0.76)。
- 调整年龄、恶性肿瘤状态和MELD评分后,ACLF分级与出院后1年无移植存活无独立关联。
核心结论
- 在这项全国性队列研究中,ICU入院时ACLF分级未独立影响出院后1年无移植存活。
- 年龄、是否存在恶性肿瘤和肝病严重程度在影响出院后无移植存活方面起更突出作用。
研究设计与样本
- 荷兰全国性观察性队列研究,纳入2012年至2020年入住ICU的肝硬化或肝硬化门静脉高压首次并发症患者。
- 共纳入3035例患者,其中1819例(59.9%)为ACLF-3。
- 采用未调整Kaplan-Meier生存曲线和调整Cox比例风险模型评估ICU入院时ACLF分级对出院后1年无移植存活的影响。
主要发现
- 3035例患者中,1420例(46.8%)在ICU入院后存活出院。
- 出院后1年无移植存活的总体概率为0.61(95%CI 0.59-0.64)。
- 出院后1年无移植存活率随ICU入院时ACLF分级变化,无ACLF患者最高为0.71(95%CI 0.66-0.76),ACLF-3患者最低为0.53(95%CI 0.49-0.58)(log-rank p<0.0001)。
- 调整年龄、恶性肿瘤状态和MELD评分后,ICU入院时ACLF分级与出院后1年内肝移植或死亡风险增加无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Patients with acute decompensation of cirrhosis or acute-on-chronic liver failure (ACLF) often require intensive care unit (ICU) admission for organ support. Existing research, mostly from specialized liver transplant centers, largely addresses short-term outcomes. Our aim was to evaluate in-hospital mortality and 1-year transplant-free survival after hospital discharge in the Netherlands. METHODS: We conducted a nationwide observational cohort study, including patients with a history of cirrhosis or first complications of cirrhotic portal hypertension admitted to ICUs in the Netherlands between 2012 and 2020. The influence of ACLF grade at ICU admission on 1-year transplant-free survival after hospital discharge among hospital survivors was evaluated using unadjusted Kaplan-Meier survival curves and an adjusted Cox proportional hazard model. RESULTS: Out of the 3,035 patients, 1,819 (59.9%) had ACLF-3. 1,420 patients (46.8%) survived hospitalization after ICU admission. The overall probability of 1-year transplant-free survival after hospital discharge was 0.61 (95% CI 0.59-0.64). This rate varied with ACLF grade at ICU admission, being highest in patients without ACLF (0.71; 95% CI 0.66-0.76) and lowest in those with ACLF-3 (0.53 [95% CI 0.49-0.58]) (log-rank p <0.0001). However, after adjusting for age, malignancy status and MELD score, ACLF grade at ICU admission was not associated with an increased risk of liver transplantation or death within 1 year after hospital discharge. CONCLUSION: In this nationwide cohort study, ACLF grade at ICU admission did not independently affect 1-year transplant-free survival after hospital discharge. Instead, age, presence of malignancy and the severity of liver disease played a more prominent role in influencing transplant-free survival after hospital discharge. IMPACT AND IMPLICATIONS: Patients with acute-on-chronic liver failure often require intensive care unit (ICU) admission for organ support. In these patients, short-term mortality is high, but long-term outcomes of survivors remain unknown. Using a large nationwide cohort of ICU patients, we discovered that the severity of acute-on-chronic liver failure at ICU admission does not influence 1-year transplant-free survival after hospital discharge. Instead, age, malignancy status and overall severity of liver disease are more critical factors in determining their long-term survival.
引用
- de Haan J, Termorshuizen F, de Keizer N, et al. One-year transplant-free survival following hospital discharge after ICU admission for ACLF in the Netherlands. J Hepatol. 2024. PMID: 38479613. doi:10.1016/j.jhep.2024.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。